+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High-density lipoprotein cholesterol: a potential therapeutic target for prevention of coronary artery disease



High-density lipoprotein cholesterol: a potential therapeutic target for prevention of coronary artery disease



Preventive Cardiology 10(1): 26-30



High-density lipoprotein cholesterol has an important role in the pathophysiology of coronary artery disease. High-density lipoprotein cholesterol is becoming an increasingly important prognostic and therapeutic target. The purpose of this paper is to review the biochemical pathways involved in reverse cholesterol transport and to discuss potential, clinically based high-density lipoprotein therapies that may contribute to reduction in risk of atherosclerosis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049220353

Download citation: RISBibTeXText

PMID: 17215630

DOI: 10.1111/j.1520-037x.2007.05512.x


Related references

Rationale and design of the Department of Veterans Affairs High-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol. American Journal of Cardiology 71(1): 45-52, 1993

Low-density lipoprotein-cholesterol/high-density lipoprotein-cholesterol ratio predicts lipid-rich coronary plaque in patients with coronary artery disease--integrated-backscatter intravascular ultrasound study. Circulation Journal 74(7): 1392-1398, 2010

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. New England Journal of Medicine 341(6): 410-418, 1999

Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Journal of the American College of Cardiology 55(1): 35-41, 2009

ATP-binding cassette transporter A1 gene I823M polymorphism affects plasma high-density lipoprotein cholesterol level and modifies the effect of low high-density lipoprotein cholesterol on the risk of coronary artery disease. Cardiology 107(4): 321-328, 2007

Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 11(1): 64-70, 1991

Cholesterol esterification rates in very low density lipoprotein and low density lipoprotein depleted plasma relation to high density lipoprotein subspecies sex hyperlipidemia and coronary artery disease. Arteriosclerosis and Thrombosis 11(1): 64-70, 1991

Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients. Metabolic Syndrome and Related Disorders 8(6): 515-522, 2010

The relative role of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in coronary artery disease: evidence from large-scale statin and fibrate trials. American Journal of Cardiology 88(12-Supp-S1): 14-18, 2001

The relative role of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in coronary artery disease: evidence from large-scale statin and fibrate trials. American Journal of Cardiology 88(12a): 14n, 2001

Is low-density lipoprotein/high-density lipoprotein (LDL/HDL)-cholesterol ratio a more important predictor of vulnerable plaque in coronary artery disease than LDL- or HDL-cholesterol?. Circulation Journal 74(7): 1294-1295, 2010

Low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio as a predictor of atherosclerotic coronary artery disease The PROCAM experience. European Heart Journal 15(ABSTR Suppl. ): 163, 1994

High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. American Heart Journal 144(6 Suppl): S33, 2002

High-density lipoprotein cholesterol and the risk of obstructive coronary artery disease beyond low-density lipoprotein cholesterol in non-diabetic individuals. European Journal of Preventive Cardiology 2019: 2047487319844364, 2019

Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). American Journal of Cardiology 103(1): 41-45, 2009